Hester Biosciences buys ICAR IVRI technologies for classical swine fever, sheep pox vaccines

"Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100 per cent protection," Hester Biosciences said.

Published On 2021-04-09 07:37 GMT   |   Update On 2021-04-10 04:33 GMT
Advertisement

New Delhi: Animal healthcare firm Hester Biosciences on Thursday said it has acquired technologies from the Indian Council of Agricultural Research – Indian Veterinary Research Institute (ICAR – IVRI) for production and commercialisation of vaccines for classical swine fever and sheep pox.

Classical swine fever vaccine and sheep pox vaccine have been developed within the country by using locally isolated strains, Hester Biosciences said in a filing to BSE.

Advertisement

The technologies were developed by ICAR-IVRI and the commercialisation of the technologies was facilitated by Agrinnovate India, a company owned by the Department of Agricultural, Research & Education, Ministry of Agriculture, it added.

Read also: Alembic Pharma JV bags USFDA nod for Efinaconazole Topical Solution

"Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100 per cent protection," Hester Biosciences said.

The company plans to launch both the vaccines commercially in approximately 8 months, it added.


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News